Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel
NCT Number: NCT03756545
The research goal is to uncover the neurocognitive moderators of PTSD trajectories, by documenting clinical symptoms, cognitive functioning, and brain structure and function, one-, six- and fourteen months following a traumatic event, in a large population of survivors at initial high risk for PTSD.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Tel Aviv, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: one-, six- and fourteen months following a traumatic event
The Clinician-Administered PTSD Scale, used to assess PTSD diagnostic status and symptom severity. CAPS total symptom severity score is calculated by summing severity scores for all PTSD symptoms. We use both CAPS-V (according to DSM-4) and CAPS-5 (according to DSM-5).
Tel-Aviv Sourasky Medical Center
Other Gov
Neurobehavioral Moderators of Post-traumatic Disease Trajectories: Prospective MRI Study of Recent Trauma Survivors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03778307
Endothelial Dysfunction, Mental Disorders
Los Angeles, California, United States
View Trial DetailsNCT03973229
Mental Disorders, PTSD
Atlanta, Georgia, United States
View Trial DetailsNCT03515564
Anxiety, Anxiety Disorders
Detroit, Michigan, United States
View Trial DetailsNCT04574466
Anxiety, Anxiety Disorders
Zurich, Switzerland
View Trial Details